Generation Bio Profit Margin

Generation Bio (GBIO) currently reports a profit margin of -410.13% as of September 2025. That compares with -782.87% in the prior-year period — up 47.6% year over year. That is below the Healthcare sector average of 14.34%. Use the charts on this page to explore Generation Bio's profit margin history and peer comparisons.

Generation Bio's profit margin increased from -782.87% to -410.13% — a 47.6% year-over-year increase (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Generation Bio's profit margin of -410.13% is lower than the Healthcare sector average of 14.34%. That is roughly 2959.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Generation Bio's current -410.13% should be judged against Healthcare norms (sector average: 14.34%) and against GBIO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -410.13%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 14.34%. From there, open related valuation or income-statement pages for Generation Bio, and consider following GBIO for alerts when major investors trade the stock.